Brief Your CEO

The 18 Things You Can Do for COVID-19 that You Can’t Do for Other Testing  

Blanket Waivers relaxing kickback law restrictions standing in the way of desperately needed COVID-19 tests continue to play a crucial role in the federal government’s response to the Public Health … [Read more...]


Brief Your CEO: Explain How New DOJ Guidance Can Get Your Lab Out of FCA Hot Water

New guidance from the DOJ lays out sheds light on a crucial matter that many high-ranking lab executives are forced to confront: whether to "play ball" with the federal government when internal … [Read more...]


Brief Your CEO: Notify Your Lab Execs of Upcoming Stark Law Changes

One of the best ways to score points with your lab's executives is to warn them about legal changes before they happen and while there's still time to prepare. And now you have an opportunity to do … [Read more...]


Brief Your CEO: Real Stark Law Relief Might Actually Happen

Fool me once, shame on you; fool me twice, shame on me. That may have been your reaction when you first heard about the new CMS Request for Information (RFI) seeking input on ways to alleviate the … [Read more...]


Brief Your CEO: Medicaid Enforcement Trends & Their Impact on Labs

While they do not have to embroil themselves in the day-to-day compliance program details, the C-Suiters do need to be on top of general health care enforcement trends affecting your lab. OIG reports … [Read more...]


Brief Your CEO: New Penalties Double the Dollar Value of Protecting Your Lab from Liability

You may not realize this, but Congress has just doubled the dollar value of what you do as a compliance manager to keep your lab out of federal health care fraud hot water. How? By significantly … [Read more...]


Brief Your CEO: The New CMS Appeals Process & How to Use It to Get Medicare to Pay

While Part B lab reimbursements may be going down, the good news is that it just became easier to challenge Medicare payment denials. On Feb. 5, 2018, CMS launched a new Low Volume Appeals settlement … [Read more...]


Brief Your CEO: After 36 Years, CLIA Comes Under CMS Review

Brace yourself—and your C-suite—for more sweeping legal changes. Even as your lab makes the transition to the new, supposedly market-based PAMA Medicare Part B fee schedule for tests, big changes may … [Read more...]


Brief Your CEO: 5 Takeaways from OIG’s New Semiannual Report

Like many lab managers, you may provide a year-end compliance briefing to your executive team. If so, you will want to cover the new OIG Semiannual Report to Congress in which the agency explains what … [Read more...]


Brief Your CEO: The 4 Key Takeaways from the OIG 2016 Part B Lab Payments Report

As PAMA payment system D-Day creeps closer, the OIG issued its report on 2016 Medicare lab payments. Spoiler Alert: It was more of the same in 2016. Part B payments for lab tests over the past three … [Read more...]